OverviewPain, defined as “a sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage,”1 is one of the most common symptoms associated with cancer. Cancer pain or cancer-related pain is distinct from pain experienced by patients without malignancies. Pain occurs in approximately one quarter of patients with newly diagnosed malignancies, one third of patients undergoing treatment, and three quarters of patients with advanced disease,2–4 and is one of the symptoms patients fear most. Unrelieved pain denies patients comfort and greatly affects their activities, motivation, interactions with family and friends, and overall quality of life.The importance of relieving pain and availability of effective therapies make it imperative that physicians and nurses caring for these patients be adept at the assessment and treatment of cancer pain.5–7 This requires familiarity with the pathogenesis of cancer pain; pain assessment techniques; common barriers to the delivery of appropriate analgesia; and pertinent pharmacologic, anesthetic, neurosurgical, and behavioral approaches to the treatment of cancer pain.The most widely accepted algorithm for the treatment of cancer pain was developed by the WHO.8,9 It suggests that patients with pain be started on acetaminophen or a nonsteroidal anti-inflammatory drug (NSAID). If this is not sufficient, patients should be escalated to a weak opioid, such as codeine, and then to a strong opioid, such as morphine. Although this algorithm has served as an excellent teaching tool, the management of cancer pain is considerably more complex than this 3-tiered “cancer pain ladder”...
Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl1986;3(Supp 1):226.
Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl1986;3(Supp 1):226.
)| false
CohenMZ, EasleyMK, EllisC. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage2003;25:519–527.
CohenMZEasleyMKEllisC. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage2003;25:519–527.
)| false
SvendsenKB, AndersenS, ArnasonS. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain2005;9:195–206.
SvendsenKBAndersenSArnasonS. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain2005;9:195–206.
)| false
StjernswardJ, ColleauSM, VentafriddaV. The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. J Pain Symptom Manage1996;12:65–72.
StjernswardJColleauSMVentafriddaV. The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. J Pain Symptom Manage1996;12:65–72.
)| false
SerlinRC, MendozaTR, NakamuraY. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain1995;61:277–284.
SerlinRCMendozaTRNakamuraY. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain1995;61:277–284.
)| false
SoetengaD, FrankJ, PellinoTA. Assessment of the validity and reliability of the University of Wisconsin Children's Hospital Pain scale for Preverbal and Nonverbal Children. Pediatr Nurs1999;25:670–676.
SoetengaDFrankJPellinoTA. Assessment of the validity and reliability of the University of Wisconsin Children's Hospital Pain scale for Preverbal and Nonverbal Children. Pediatr Nurs1999;25:670–676.
)| false
American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed.Glenview, IL: American Pain Society; 2003.
American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed.Glenview, IL: American Pain Society; 2003.
)| false
MercadanteSL, BerchovichM, CasuccioA. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care2007;24:13–19.
MercadanteSLBerchovichMCasuccioA. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care2007;24:13–19.
)| false
KlepstadP, KaasaS, BorchgrevinkPC. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol2000;55:713–719.
KlepstadPKaasaSBorchgrevinkPC. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol2000;55:713–719.
)| false
KlepstadP, KaasaS, SkaugeM, BorchgrevinkPC. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. Acta Anaesthesiol Scand2000;44:656–664.
KlepstadPKaasaSSkaugeMBorchgrevinkPC. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. Acta Anaesthesiol Scand2000;44:656–664.
)| false
KornickCA, Santiago-PalmaJ, KhojainovaNL. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer2001;92:3056–3061.
KornickCASantiago-PalmaJKhojainovaNL. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer2001;92:3056–3061.
)| false
PortenoyRK, FoleyKM, StulmanJ. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure. Pain1991;47:13–19.
PortenoyRKFoleyKMStulmanJ. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure. Pain1991;47:13–19.
)| false
BarkinRL, BarkinSJ, BarkinDS. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther2006;13:534–542.
BarkinRLBarkinSJBarkinDS. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther2006;13:534–542.
)| false
AubertR, StanekEJ, YaoJ. Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract CRA508.
AubertRStanekEJYaoJ. Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract CRA508.)| false
DezentjeV, Van BlijderveenNJ, GelderblomH. Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: a pharmacoepidemiologic study [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract CRA509.
DezentjeVVan BlijderveenNJGelderblomH. Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: a pharmacoepidemiologic study [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract CRA509.)| false
McNicolE, Horowicz-MehlerN, FiskRA. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain2003;4:231–256.
McNicolEHorowicz-MehlerNFiskRA. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain2003;4:231–256.
)| false
BoettgerS, BreitbartW. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care2005;3:227–237.
BoettgerSBreitbartW. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care2005;3:227–237.
)| false
BreitbartW, MarottaR, PlattMM. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry1996;153:231–237.
BreitbartWMarottaRPlattMM. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry1996;153:231–237.
)| false
BrueraE, BelzileM, NeumannC. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage2000;19:427–435.
BrueraEBelzileMNeumannC. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage2000;19:427–435.
)| false
MarinellaMA. Acute colonic pseudo-obstruction complicated by cecal perforation in a patient with Parkinson's disease. South Med J1997;90:1023–1026.
MarinellaMA. Acute colonic pseudo-obstruction complicated by cecal perforation in a patient with Parkinson's disease. South Med J1997;90:1023–1026.
)| false
TarcatuD, TamasdanC, MorylN, ObbensE. Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. J Opioid Manag2007;3:167–170.
TarcatuDTamasdanCMorylNObbensE. Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. J Opioid Manag2007;3:167–170.
)| false
HawleyPH, ByeonJJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med2008;11:575–581.
HawleyPHByeonJJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med2008;11:575–581.
)| false
MercadanteS, ArcuriE, FerreraP. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage2005;30:485–491.
MercadanteSArcuriEFerreraP. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage2005;30:485–491.
)| false
GreenbergHS, TarenJ, EnsmingerWD, DoanK. Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg1982;57:360–364.
GreenbergHSTarenJEnsmingerWDDoanK. Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg1982;57:360–364.
)| false
JinY, DestaZ, StearnsV. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst2005;97:30–39.
JinYDestaZStearnsV. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst2005;97:30–39.
)| false
StocklerM, VardyJ, PillaiA, WarrD. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol2004;22:3389–3394.
StocklerMVardyJPillaiAWarrD. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol2004;22:3389–3394.
)| false